Antimicrobial Exclusivity Vouchers ‘The Only Way To Go’
Many EU Countries, Generics Firms & Others Oppose The Voucher Idea
Executive Summary
“If you don’t like it, come up with a better solution,” proponents of the transferable exclusivity voucher scheme said at a webinar on tackling antimicrobial resistance.
You may also be interested in...
Off-Patent Industry Proposes Extensions To EU Market Protection Rather Than Data Exclusivity
Medicines for Europe proposed several alterations to the European Commission’s planned changes to exclusivity incentives at its recent Regulatory and Pharmacovigilance Conference in Brussels, most notably suggesting that the proposed extensions to data exclusivity should instead apply to market exclusivity.
Medicines For Europe Proposes Revised Remodulation To EU Exclusivity Proposals
Medicines for Europe proposed several alterations to the European Commission’s planted alterations to market exclusivity incentives at its recent Regulatory and Pharmacovigilance Conference in Brussels, most prominently that various proposed extensions to data exclusivity should instead be used to extend market exclusivity.
Tackling AMR: OECD Says Greater Investment Needed In Later-Stage Drug R&D
Governments should increase financial resources for novel antimicrobial drug candidates in the later stages of development and tackle shortages of existing, underused antibiotics to combat antimicrobial resistance, says a new report from the OECD.